Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Mersana Therapeutics, Inc.”

36 pharma patents match "Mersana Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 36
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 36 pharmaceutical patents matching "Mersana Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

36 results for “Mersana Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 9738720

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  2. US 9555112

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  3. US 9254339

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted
  4. US 9144615

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted
  5. US 8821850

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  6. US 8815226

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  7. US 8808679

    Auristatin compounds and conjugates thereof

    Mersana Therapeutics, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  8. US 8685383

    Protein-polymer-drug conjugates

    Mersana Therapeutics, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  9. US 8524214

    Polyal drug conjugates comprising variable rate-releasing linkers

    Mersana Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  10. US 8491880

    Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates

    Mersana Therapeutics, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted
  11. US 8399512

    Biocompatible biodegradable fumagillin analog conjugates

    Mersana Therapeutics, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  12. US 8349308

    Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted